LYC Healthcare Bhd
KLSE:LYC
Balance Sheet
Balance Sheet Decomposition
LYC Healthcare Bhd
LYC Healthcare Bhd
Balance Sheet
LYC Healthcare Bhd
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
11
|
8
|
5
|
4
|
5
|
3
|
5
|
3
|
6
|
10
|
8
|
5
|
13
|
10
|
4
|
15
|
22
|
40
|
25
|
17
|
|
| Cash |
11
|
8
|
5
|
4
|
5
|
3
|
5
|
3
|
6
|
10
|
8
|
5
|
13
|
10
|
4
|
15
|
22
|
40
|
25
|
17
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
3
|
5
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
4
|
5
|
3
|
2
|
5
|
8
|
6
|
5
|
4
|
8
|
11
|
10
|
6
|
5
|
4
|
10
|
24
|
18
|
28
|
27
|
|
| Accounts Receivables |
3
|
5
|
3
|
2
|
4
|
8
|
6
|
4
|
4
|
8
|
11
|
9
|
6
|
5
|
4
|
10
|
14
|
18
|
27
|
26
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
10
|
1
|
1
|
1
|
|
| Inventory |
3
|
5
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
1
|
6
|
8
|
10
|
9
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
17
|
18
|
9
|
8
|
11
|
17
|
16
|
11
|
17
|
22
|
20
|
17
|
20
|
15
|
8
|
30
|
52
|
66
|
62
|
54
|
|
| PP&E Net |
2
|
2
|
2
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
5
|
4
|
7
|
23
|
44
|
59
|
61
|
71
|
91
|
101
|
|
| PP&E Gross |
2
|
2
|
2
|
5
|
5
|
5
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
3
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
36
|
63
|
72
|
85
|
77
|
|
| Goodwill |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
4
|
4
|
1
|
7
|
6
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
24
N/A
|
25
+4%
|
13
-49%
|
13
+4%
|
16
+20%
|
21
+37%
|
21
-4%
|
16
-20%
|
22
+31%
|
27
+26%
|
27
-1%
|
23
-16%
|
31
+38%
|
42
+36%
|
57
+35%
|
136
+138%
|
183
+35%
|
216
+18%
|
243
+13%
|
235
-3%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
1
|
2
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
13
|
0
|
11
|
9
|
2
|
4
|
11
|
10
|
13
|
27
|
30
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
6
|
10
|
7
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
6
|
5
|
8
|
63
|
68
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
6
|
5
|
15
|
13
|
9
|
|
| Total Current Liabilities |
1
|
3
|
1
|
3
|
7
|
12
|
10
|
9
|
9
|
13
|
13
|
12
|
10
|
5
|
9
|
22
|
20
|
37
|
103
|
117
|
|
| Long-Term Debt |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
14
|
26
|
87
|
119
|
95
|
59
|
60
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
6
|
14
|
34
|
39
|
41
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
2
|
2
|
|
| Total Liabilities |
2
N/A
|
3
+21%
|
2
-35%
|
6
+198%
|
10
+75%
|
14
+48%
|
13
-11%
|
12
-8%
|
11
-4%
|
16
+44%
|
16
+1%
|
13
-18%
|
11
-18%
|
19
+76%
|
36
+85%
|
116
+226%
|
156
+34%
|
169
+9%
|
204
+21%
|
220
+8%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
18
|
20
|
20
|
29
|
47
|
59
|
67
|
78
|
58
|
91
|
101
|
101
|
|
| Retained Earnings |
3
|
3
|
8
|
11
|
12
|
11
|
11
|
14
|
16
|
18
|
18
|
20
|
26
|
36
|
46
|
58
|
30
|
44
|
62
|
86
|
|
| Additional Paid In Capital |
10
|
10
|
10
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
22
+3%
|
11
-51%
|
8
-30%
|
6
-21%
|
7
+20%
|
8
+9%
|
5
-39%
|
10
+116%
|
11
+7%
|
11
-4%
|
9
-13%
|
20
+120%
|
23
+13%
|
21
-7%
|
20
-8%
|
28
+40%
|
47
+70%
|
39
-17%
|
15
-61%
|
|
| Total Liabilities & Equity |
24
N/A
|
25
+4%
|
13
-49%
|
13
+4%
|
16
+20%
|
21
+37%
|
21
-4%
|
16
-20%
|
22
+31%
|
27
+26%
|
27
-1%
|
23
-16%
|
31
+38%
|
42
+36%
|
57
+35%
|
136
+138%
|
183
+35%
|
216
+18%
|
243
+13%
|
235
-3%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
179
|
197
|
197
|
201
|
258
|
325
|
355
|
392
|
465
|
650
|
715
|
715
|
|